WBO:EVT (Germany)  
Evotec SE logo

Evotec SE

€ 19.15 (+3.91%) Oct 4
On watch
P/E:
369.78
P/B:
2.56
Market Cap:
€ 3.39B ($ 3.36B)
Enterprise V:
€ 2.98B ($ 2.96B)
Volume:
-
Avg Vol (2M):
200.00
Also Trade In:
Volume:
-
Market Cap €:
3.39B
Market Cap $:
3.36B
PE Ratio:
369.78
Avg Vol (2-Month):
200.00
Enterprise Value €:
2.98B
Enterprise Value $:
2.96B
PB Ratio:
2.56
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.
Name Current Vs Industry Vs History
Cash-To-Debt 1.84
Equity-to-Asset 0.56
Debt-to-Equity 0.38
Debt-to-EBITDA 11.43
Interest Coverage 2.3
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.47
Distress
Grey
Safe
Beneish M-Score -2.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.77
9-Day RSI 49.75
14-Day RSI 42.06
6-1 Month Momentum % -22.83
12-1 Month Momentum % -46.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.57
Quick Ratio 3.48
Cash Ratio 2.78
Days Inventory 16.77
Days Sales Outstanding 53.49
Days Payable 46.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.9

Financials (Next Earnings Date:2022-11-09)

WBO:EVT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 683.607
EPS (TTM) (€) 0.05
Beta 0.71
Volatility % 42.13
14-Day RSI 42.06
14-Day ATR (€) 0.531478
20-Day SMA (€) 19.628
12-1 Month Momentum % -46.05
52-Week Range (€) 17.3 - 45.41
Shares Outstanding (Mil) 176.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evotec SE Filings

Document Form Filing Date
No Filing Data

Evotec SE Analysis

Share your research